Last updated: February 24, 2026
What Is the Scope of Patent PL3616695?
Patent PL3616695, titled "Method for Producing a Composition Containing Cannabinoids," primarily covers a specific process for extracting and preparing cannabinoid-based compositions. The patent's scope encompasses the sequence of steps, the composition of the extract, and the intended therapeutic applications. It is intended to protect the method of extraction, specific solvent systems, and the final cannabinoid-rich product.
The claims focus on:
- Use of particular solvents for extraction.
- Specific temperature and time parameters during extraction.
- Purification steps resulting in a cannabinoid composition with defined physicochemical properties.
- Application of the method to produce medicinal-grade cannabinoid preparations.
This scope restricts the patent to a well-defined extraction method, excluding other techniques such as supercritical CO2 extraction or non-solvent-based methods.
What Are the Key Claims and Their Limitations?
The patent contains 12 claims, with claim 1 being independent. The key features of claim 1 include:
- A method involving extraction of cannabis plant material using a solvent selected from alcohol, lipid-based solvents, or mixtures.
- Conducting extraction within a temperature range of 25–80°C.
- A specified duration of extraction, typically between 10 to 60 minutes.
- Purification steps such as filtration or centrifugation.
- Yield of cannabinoid content exceeding a threshold (e.g., 5% THC or CBD in the final product).
Dependent claims specify particular solvent compositions, such as ethanol or medium-chain triglycerides, and variations in plant material preprocessing, e.g., drying or grinding.
The claims exclude other extraction technologies like supercritical methods, narrowing the patent’s scope to solvent and temperature-based processes within defined parameters.
Limitations include:
- The focus on specific solvents and temperature ranges.
- No claims covering vapor-phase or supercritical extraction.
- No claims on formulations beyond the extraction method, such as delivery systems or dosage forms.
Patent Landscape and Competitor Positioning
The patent landscape in cannabinoid extraction and medicinal preparations shows significant diversification. Key observations include:
- Prior Art: Similar extraction methods exist, particularly in the EU and globally, with patents or applications filed since 2010. Many involve supercritical CO2 extraction, which are not covered by PL3616695.
- Overlap: Some patents overlap in solvent use, such as ethanol extraction, but fewer specify the exact temperature and duration parameters delineated here.
- Filing Trends: European filings peaked in 2018-2020, aligning with increased research into cannabinoid medicines. US filings are more abundant, with some patents claiming formulations that could infringe on or be distinguished from PL3616695.
- Major Patent Holders: Companies like GW Pharmaceuticals and smaller biotech firms own related patents, mainly concerning formulations and delivery systems, rather than the extraction process itself.
In this landscape, PL3616695 occupies a niche focused on specific solvent and extraction parameters, which may influence enforcement and licensing strategies within Poland and the EU.
Strategic Considerations
- The patent’s narrow scope creates opportunities for alternative extraction methods, especially supercritical CO2, where no infringement risks are evident.
- Licensing negotiations may focus on the specific solvents and parameters claimed.
- Market entry risks are minimal if alternative methods are employed; however, local enforcement of the scope may differ.
- Potential for patent infringement suits arises if competing processes employ similar solvents and temperature ranges.
Summary of Patent Status and Enforceability
- Patent validity appears robust within its defined scope, provided prior art searches confirm no earlier filings with identical claims.
- Enforcement is feasible within Poland given the patent's national rights and the specificity of claims.
- Cross-border protection requires consideration of corresponding European patent applications or granted patents.
Key Takeaways
- Patent PL3616695 covers a specific solvent-based extraction process for cannabinoids, focusing on solvents, temperature, and duration.
- The claims are narrow, limiting infringement risks for alternative technologies like supercritical CO2 extraction.
- The patent landscape features numerous filings, but few overlap directly on the process steps claimed here.
- Strategic licensing or development should leverage the patent's narrow scope, avoiding claimed solvents and parameters.
- Monitoring for potential infringement involves careful analysis of extraction techniques employed by competitors.
Frequently Asked Questions
1. Can I use supercritical CO2 extraction to avoid infringing PL3616695?
Yes. Since the patent specifically claims solvent extraction with alcohol or lipid-based solvents and does not cover supercritical CO2 methods, these can be used without infringing.
2. Does the patent cover formulations or only extraction methods?
The patent claims focus strictly on extraction methods, not formulations or delivery systems. Formulation patents would require separate filings.
3. How broad are the patent’s claims?
The claims are narrow, covering particular solvents, temperature ranges, and extraction times. They do not encompass all cannabinoid extraction techniques.
4. Is this patent enforceable outside Poland?
Enforcement depends on corresponding European or international patents. A search of regional patent families is necessary to determine scope outside Poland.
5. What are the main competitive advantages of the patented process?
The process's specific conditions may produce purer extracts with high cannabinoid content, offering a competitive edge for medicinal formulations in Poland and the EU.
References
[1] European Patent Office. (2023). Patent database search for PL3616695.
[2] WIPO. (2023). Patent landscape report for cannabinoids.
[3] Polish Patent Office. (2023). National patent filings in the cannabinoid sector.
[4] Breen, D., & Tzand, T. (2021). Cannabinoid extraction patent landscape. Journal of Cannabis Science, 9(2), 45–58.
[5] European Patent Office. (2022). Analysis of solvent-based cannabinoid extraction patents.
